Literature DB >> 26504007

A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.

Tatsuya Yoshimasu1, Takuya Ohashi2, Shoji Oura2, Yozo Kokawa2, Mitsumasa Kawago2, Yoshimitsu Hirai2, Miwako Miyasaka2, Haruka Nishiguchi2, Sayoko Kawashima2, Yumi Yata2, Mariko Honda2, Takahiro Fujimoto2, Yoshitaka Okamura2.   

Abstract

In the present article, we quantitatively evaluated the dose-response relationship of hormetic reactions of anticancer agents in vitro. Serial dilutions of gemcitabine, cisplatin, 5-fluorouracil, vinorelbine, and paclitaxel were administered to the A549 non-small-cell lung cancer cell line. The bi-phasic sigmoidal curve with hormetic and cytotoxic effects is given by the formula y=(a-b/(1+exp(c(*)log(x)-d)))/(1+exp(e(*)log(x)-f)), that was used to perform a non-linear least square regression. The dose-responses of the five anticancer agents were fitted to this equation. Gemcitabine and 5-fluorouracil, which had the lowest ED50 for their hormetic reaction, had the most pronounced promotive effects out of the five anticancer agents tested. The hormetic reaction progressed exponentially with culturing time. Our theoretical model will be useful in predicting how hormetic reactions affect patients with malignant tumors. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Hormesis; chemotherapy; lung cancer

Mesh:

Substances:

Year:  2015        PMID: 26504007

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

Review 1.  Which factors matter the most? Revisiting and dissecting antibody therapeutic doses.

Authors:  Yu Tang; Xiaobing Li; Yanguang Cao
Journal:  Drug Discov Today       Date:  2021-04-22       Impact factor: 8.369

2.  The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.

Authors:  Richard E Kast; Nicolas Skuli; Samuel Cos; Georg Karpel-Massler; Yusuke Shiozawa; Ran Goshen; Marc-Eric Halatsch
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-07-11

3.  Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.

Authors:  Josué Carvalho; Artur Paiva; Maria Paula Cabral Campello; António Paulo; Jean-Louis Mergny; Gilmar F Salgado; João A Queiroz; Carla Cruz
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

4.  Quantitative Evaluation of Hormesis in Breast Cancer Using Histoculture Drug Response Assay.

Authors:  Yuka Aoishi; Tatsuya Yoshimasu; Shoji Oura; Mitsumasa Kawago; Yoshimitsu Hirai; Miwako Miyasaka; Takuya Ohashi; Yoshiharu Nishimura
Journal:  Dose Response       Date:  2019-12-26       Impact factor: 2.658

5.  Performance of Chlorella Vulgaris Exposed to Heavy Metal Mixtures: Linking Measured Endpoints and Mechanisms.

Authors:  Nora Expósito; Roberta Carafa; Vikas Kumar; Jordi Sierra; Marta Schuhmacher; Gemma Giménez Papiol
Journal:  Int J Environ Res Public Health       Date:  2021-01-25       Impact factor: 3.390

6.  Effect of Pseudomonas moorei KB4 Cells' Immobilisation on Their Degradation Potential and Tolerance towards Paracetamol.

Authors:  Robert Surma; Danuta Wojcieszyńska; Jagna Karcz; Urszula Guzik
Journal:  Molecules       Date:  2021-02-04       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.